Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Budhu Website

Anuradha S. Budhu, Ph.D.

Portait Photo of Anuradha Budhu
Laboratory of Human Carcinogenesis
Liver Carcinogenesis Section
Staff Scientist
Center for Cancer Research
National Cancer Institute
Building 37, Room 3050A
Bethesda, MD 20892
Phone:  
301-496-5887
Fax:  
301-496-0497
E-Mail:  
budhua@mail.nih.gov

Biography

Dr. Anuradha Budhu began her scientific career as a student researcher in the Undergraduate Biology Research Program (UBRP) at the University of Arizona, studying gene expression patterns in the larval brain of Drosophila Melanogaster. These studies were continued at The University of Adelaide in Australia through the UBRP Biomedical Research Abroad Vistas Open (Bravo!) Program funded by a Howard Hughes fellowship. After completion of her bachelor's honors degree (Cum Laude)in Biochemistry/Molecular and Cellular Biology from the University of Arizona, Dr. Budhu joined the graduate program in Biochemistry at Cornell University, where she earned her Ph.D. studying the roles of retinoids in mammary carcinoma. In 2002, she joined the Laboratory of Human Carcinogenesis at NCI as a Cancer Research Training Award (CRTA) postdoctoral fellow in the Liver Carcinogenesis Section. She was promoted to Staff Scientist in 2007. Dr. Budhu has authored over 35 peer-reviewed articles and 6 book chapters. Dr. Budhu is an active member of the Staff Scientist and Staff Clinician (SSSC) community at CCR, serving as Co-Chair of the SSSC Communications Committee and Editor-in-Chief of the SSSC newsletter (The Dossier). She is the recipient of several awards, including the CCR's Outstanding Postdoctoral Award and the NCI Director's Innovation Award.

Research

Dr. Budhu's research interests include studies of human liver cancer, specifically addressing the elucidation of molecular mechanisms involved in hepatocarcinogenesis, including metastasis. These avenues are explored through global molecular and genetic profiling as well as functional experimentation with an emphasis on clinical translation.

This page was last updated on 2/21/2013.